Quantification of impact of COVID-19 pandemic on cancer screening programmes – a case study from Argentina, Bangladesh, Colombia, Morocco, Sri Lanka, and Thailand

Autores
Lucas, Eric; Murillo, Raul; Arrossi, Silvina; Bárcena, Martin; Chami, Youssef; Nessa, Ashrafun; Perera, Suraj; Silva, Padmaka; Sangrajrang, Suleeporn; Muwonge, Richard; Basu, Partha
Año de publicación
2023
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
It is quite well documented that the COVID-19 pandemic disrupted cancer screening services in all countries, irrespective of their resources and healthcare settings. While quantitative estimates on reduction in volume of screening tests or diagnostic evaluation are readily available from the high-income countries, very little data are available from the low-and middle-income countries (LMICs). From the CanScreen5 global cancer screening data repository we identified six LMICs through purposive sampling based on the availability of cancer screening data at least for the years 2019 and 2020. These countries represented those in high human development index (HDI) categories (Argentina, Colombia, Sri Lanka, and Thailand) and medium HDI categories (Bangladesh and Morocco). No data were available from low HDI countries to perform similar analysis. The reduction in the volume of tests in 2020 compared to the previous year ranged from 14.1% in Bangladesh to 72.9% in Argentina (regional programme) for cervical screening, from 14.2% in Bangladesh to 49.4% in Morocco for breast cancer screening and 30.7% in Thailand for colorectal cancer screening. Number of colposcopies was reduced in 2020 compared to previous year by 88.9% in Argentina, 38.2% in Colombia, 27.4% in Bangladesh, and 52.2% in Morocco. The reduction in detection rates of CIN 2 or worse lesions ranged from 20.7% in Morocco to 45.4% in Argentina. Reduction of breast cancer detection by 19.1% was reported from Morocco. No association of the impact of pandemic could be seen with HDI categories. Quantifying the impact of service disruptions in screening and diagnostic tests will allow the programmes to strategize how to ramp up services to clear the back-logs in screening and more crucially in further evaluation of screen positives. The data can be used to estimate the impact on stage distribution and avoidable mortality from these common cancers.
Fil: Lucas, Eric. International Agency for Research on Cancer; Francia
Fil: Murillo, Raul. Hospital Universitario San Ignacio; Colombia
Fil: Arrossi, Silvina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Centro de Estudio de Estado y Sociedad; Argentina
Fil: Bárcena, Martin. Instituto Provincial del Cáncer; Argentina
Fil: Chami, Youssef. Foundation Lalla Salma Cancer prevention and treatment; Marruecos
Fil: Nessa, Ashrafun. Bangabandhu Sheikh Mujib Medical University; Bangladesh
Fil: Perera, Suraj. Ministry Of Health Colombo; Sri Lanka
Fil: Silva, Padmaka. Ministry Of Health Colombo; Sri Lanka
Fil: Sangrajrang, Suleeporn. National Cancer Institute of Thailand; Tailandia
Fil: Muwonge, Richard. International Agency for Research on Cancer; Francia
Fil: Basu, Partha. International Agency for Research on Cancer; Francia
Materia
COVID-19 pandemic
CANCER SCREENING
IMPACT
Argentina, Bangladesh, Colombia, Morocco, Sri Lanka, and Thailand
Nivel de accesibilidad
acceso abierto
Condiciones de uso
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
Repositorio
CONICET Digital (CONICET)
Institución
Consejo Nacional de Investigaciones Científicas y Técnicas
OAI Identificador
oai:ri.conicet.gov.ar:11336/221578

id CONICETDig_943656742e60b6216b0c20b300e2d710
oai_identifier_str oai:ri.conicet.gov.ar:11336/221578
network_acronym_str CONICETDig
repository_id_str 3498
network_name_str CONICET Digital (CONICET)
spelling Quantification of impact of COVID-19 pandemic on cancer screening programmes – a case study from Argentina, Bangladesh, Colombia, Morocco, Sri Lanka, and ThailandLucas, EricMurillo, RaulArrossi, SilvinaBárcena, MartinChami, YoussefNessa, AshrafunPerera, SurajSilva, PadmakaSangrajrang, SuleepornMuwonge, RichardBasu, ParthaCOVID-19 pandemicCANCER SCREENINGIMPACTArgentina, Bangladesh, Colombia, Morocco, Sri Lanka, and Thailandhttps://purl.org/becyt/ford/3.3https://purl.org/becyt/ford/3It is quite well documented that the COVID-19 pandemic disrupted cancer screening services in all countries, irrespective of their resources and healthcare settings. While quantitative estimates on reduction in volume of screening tests or diagnostic evaluation are readily available from the high-income countries, very little data are available from the low-and middle-income countries (LMICs). From the CanScreen5 global cancer screening data repository we identified six LMICs through purposive sampling based on the availability of cancer screening data at least for the years 2019 and 2020. These countries represented those in high human development index (HDI) categories (Argentina, Colombia, Sri Lanka, and Thailand) and medium HDI categories (Bangladesh and Morocco). No data were available from low HDI countries to perform similar analysis. The reduction in the volume of tests in 2020 compared to the previous year ranged from 14.1% in Bangladesh to 72.9% in Argentina (regional programme) for cervical screening, from 14.2% in Bangladesh to 49.4% in Morocco for breast cancer screening and 30.7% in Thailand for colorectal cancer screening. Number of colposcopies was reduced in 2020 compared to previous year by 88.9% in Argentina, 38.2% in Colombia, 27.4% in Bangladesh, and 52.2% in Morocco. The reduction in detection rates of CIN 2 or worse lesions ranged from 20.7% in Morocco to 45.4% in Argentina. Reduction of breast cancer detection by 19.1% was reported from Morocco. No association of the impact of pandemic could be seen with HDI categories. Quantifying the impact of service disruptions in screening and diagnostic tests will allow the programmes to strategize how to ramp up services to clear the back-logs in screening and more crucially in further evaluation of screen positives. The data can be used to estimate the impact on stage distribution and avoidable mortality from these common cancers.Fil: Lucas, Eric. International Agency for Research on Cancer; FranciaFil: Murillo, Raul. Hospital Universitario San Ignacio; ColombiaFil: Arrossi, Silvina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Centro de Estudio de Estado y Sociedad; ArgentinaFil: Bárcena, Martin. Instituto Provincial del Cáncer; ArgentinaFil: Chami, Youssef. Foundation Lalla Salma Cancer prevention and treatment; MarruecosFil: Nessa, Ashrafun. Bangabandhu Sheikh Mujib Medical University; BangladeshFil: Perera, Suraj. Ministry Of Health Colombo; Sri LankaFil: Silva, Padmaka. Ministry Of Health Colombo; Sri LankaFil: Sangrajrang, Suleeporn. National Cancer Institute of Thailand; TailandiaFil: Muwonge, Richard. International Agency for Research on Cancer; FranciaFil: Basu, Partha. International Agency for Research on Cancer; FranciaeLife Sciences Publications Ltd2023-05info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/221578Lucas, Eric; Murillo, Raul; Arrossi, Silvina; Bárcena, Martin; Chami, Youssef; et al.; Quantification of impact of COVID-19 pandemic on cancer screening programmes – a case study from Argentina, Bangladesh, Colombia, Morocco, Sri Lanka, and Thailand; eLife Sciences Publications Ltd; eLife; 12; 5-2023; 1-182050-084XCONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/doi/10.7554/eLife.86527info:eu-repo/semantics/altIdentifier/url/https://elifesciences.org/articles/86527info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-03T09:48:28Zoai:ri.conicet.gov.ar:11336/221578instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-03 09:48:29.256CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
dc.title.none.fl_str_mv Quantification of impact of COVID-19 pandemic on cancer screening programmes – a case study from Argentina, Bangladesh, Colombia, Morocco, Sri Lanka, and Thailand
title Quantification of impact of COVID-19 pandemic on cancer screening programmes – a case study from Argentina, Bangladesh, Colombia, Morocco, Sri Lanka, and Thailand
spellingShingle Quantification of impact of COVID-19 pandemic on cancer screening programmes – a case study from Argentina, Bangladesh, Colombia, Morocco, Sri Lanka, and Thailand
Lucas, Eric
COVID-19 pandemic
CANCER SCREENING
IMPACT
Argentina, Bangladesh, Colombia, Morocco, Sri Lanka, and Thailand
title_short Quantification of impact of COVID-19 pandemic on cancer screening programmes – a case study from Argentina, Bangladesh, Colombia, Morocco, Sri Lanka, and Thailand
title_full Quantification of impact of COVID-19 pandemic on cancer screening programmes – a case study from Argentina, Bangladesh, Colombia, Morocco, Sri Lanka, and Thailand
title_fullStr Quantification of impact of COVID-19 pandemic on cancer screening programmes – a case study from Argentina, Bangladesh, Colombia, Morocco, Sri Lanka, and Thailand
title_full_unstemmed Quantification of impact of COVID-19 pandemic on cancer screening programmes – a case study from Argentina, Bangladesh, Colombia, Morocco, Sri Lanka, and Thailand
title_sort Quantification of impact of COVID-19 pandemic on cancer screening programmes – a case study from Argentina, Bangladesh, Colombia, Morocco, Sri Lanka, and Thailand
dc.creator.none.fl_str_mv Lucas, Eric
Murillo, Raul
Arrossi, Silvina
Bárcena, Martin
Chami, Youssef
Nessa, Ashrafun
Perera, Suraj
Silva, Padmaka
Sangrajrang, Suleeporn
Muwonge, Richard
Basu, Partha
author Lucas, Eric
author_facet Lucas, Eric
Murillo, Raul
Arrossi, Silvina
Bárcena, Martin
Chami, Youssef
Nessa, Ashrafun
Perera, Suraj
Silva, Padmaka
Sangrajrang, Suleeporn
Muwonge, Richard
Basu, Partha
author_role author
author2 Murillo, Raul
Arrossi, Silvina
Bárcena, Martin
Chami, Youssef
Nessa, Ashrafun
Perera, Suraj
Silva, Padmaka
Sangrajrang, Suleeporn
Muwonge, Richard
Basu, Partha
author2_role author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv COVID-19 pandemic
CANCER SCREENING
IMPACT
Argentina, Bangladesh, Colombia, Morocco, Sri Lanka, and Thailand
topic COVID-19 pandemic
CANCER SCREENING
IMPACT
Argentina, Bangladesh, Colombia, Morocco, Sri Lanka, and Thailand
purl_subject.fl_str_mv https://purl.org/becyt/ford/3.3
https://purl.org/becyt/ford/3
dc.description.none.fl_txt_mv It is quite well documented that the COVID-19 pandemic disrupted cancer screening services in all countries, irrespective of their resources and healthcare settings. While quantitative estimates on reduction in volume of screening tests or diagnostic evaluation are readily available from the high-income countries, very little data are available from the low-and middle-income countries (LMICs). From the CanScreen5 global cancer screening data repository we identified six LMICs through purposive sampling based on the availability of cancer screening data at least for the years 2019 and 2020. These countries represented those in high human development index (HDI) categories (Argentina, Colombia, Sri Lanka, and Thailand) and medium HDI categories (Bangladesh and Morocco). No data were available from low HDI countries to perform similar analysis. The reduction in the volume of tests in 2020 compared to the previous year ranged from 14.1% in Bangladesh to 72.9% in Argentina (regional programme) for cervical screening, from 14.2% in Bangladesh to 49.4% in Morocco for breast cancer screening and 30.7% in Thailand for colorectal cancer screening. Number of colposcopies was reduced in 2020 compared to previous year by 88.9% in Argentina, 38.2% in Colombia, 27.4% in Bangladesh, and 52.2% in Morocco. The reduction in detection rates of CIN 2 or worse lesions ranged from 20.7% in Morocco to 45.4% in Argentina. Reduction of breast cancer detection by 19.1% was reported from Morocco. No association of the impact of pandemic could be seen with HDI categories. Quantifying the impact of service disruptions in screening and diagnostic tests will allow the programmes to strategize how to ramp up services to clear the back-logs in screening and more crucially in further evaluation of screen positives. The data can be used to estimate the impact on stage distribution and avoidable mortality from these common cancers.
Fil: Lucas, Eric. International Agency for Research on Cancer; Francia
Fil: Murillo, Raul. Hospital Universitario San Ignacio; Colombia
Fil: Arrossi, Silvina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Centro de Estudio de Estado y Sociedad; Argentina
Fil: Bárcena, Martin. Instituto Provincial del Cáncer; Argentina
Fil: Chami, Youssef. Foundation Lalla Salma Cancer prevention and treatment; Marruecos
Fil: Nessa, Ashrafun. Bangabandhu Sheikh Mujib Medical University; Bangladesh
Fil: Perera, Suraj. Ministry Of Health Colombo; Sri Lanka
Fil: Silva, Padmaka. Ministry Of Health Colombo; Sri Lanka
Fil: Sangrajrang, Suleeporn. National Cancer Institute of Thailand; Tailandia
Fil: Muwonge, Richard. International Agency for Research on Cancer; Francia
Fil: Basu, Partha. International Agency for Research on Cancer; Francia
description It is quite well documented that the COVID-19 pandemic disrupted cancer screening services in all countries, irrespective of their resources and healthcare settings. While quantitative estimates on reduction in volume of screening tests or diagnostic evaluation are readily available from the high-income countries, very little data are available from the low-and middle-income countries (LMICs). From the CanScreen5 global cancer screening data repository we identified six LMICs through purposive sampling based on the availability of cancer screening data at least for the years 2019 and 2020. These countries represented those in high human development index (HDI) categories (Argentina, Colombia, Sri Lanka, and Thailand) and medium HDI categories (Bangladesh and Morocco). No data were available from low HDI countries to perform similar analysis. The reduction in the volume of tests in 2020 compared to the previous year ranged from 14.1% in Bangladesh to 72.9% in Argentina (regional programme) for cervical screening, from 14.2% in Bangladesh to 49.4% in Morocco for breast cancer screening and 30.7% in Thailand for colorectal cancer screening. Number of colposcopies was reduced in 2020 compared to previous year by 88.9% in Argentina, 38.2% in Colombia, 27.4% in Bangladesh, and 52.2% in Morocco. The reduction in detection rates of CIN 2 or worse lesions ranged from 20.7% in Morocco to 45.4% in Argentina. Reduction of breast cancer detection by 19.1% was reported from Morocco. No association of the impact of pandemic could be seen with HDI categories. Quantifying the impact of service disruptions in screening and diagnostic tests will allow the programmes to strategize how to ramp up services to clear the back-logs in screening and more crucially in further evaluation of screen positives. The data can be used to estimate the impact on stage distribution and avoidable mortality from these common cancers.
publishDate 2023
dc.date.none.fl_str_mv 2023-05
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/11336/221578
Lucas, Eric; Murillo, Raul; Arrossi, Silvina; Bárcena, Martin; Chami, Youssef; et al.; Quantification of impact of COVID-19 pandemic on cancer screening programmes – a case study from Argentina, Bangladesh, Colombia, Morocco, Sri Lanka, and Thailand; eLife Sciences Publications Ltd; eLife; 12; 5-2023; 1-18
2050-084X
CONICET Digital
CONICET
url http://hdl.handle.net/11336/221578
identifier_str_mv Lucas, Eric; Murillo, Raul; Arrossi, Silvina; Bárcena, Martin; Chami, Youssef; et al.; Quantification of impact of COVID-19 pandemic on cancer screening programmes – a case study from Argentina, Bangladesh, Colombia, Morocco, Sri Lanka, and Thailand; eLife Sciences Publications Ltd; eLife; 12; 5-2023; 1-18
2050-084X
CONICET Digital
CONICET
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/doi/10.7554/eLife.86527
info:eu-repo/semantics/altIdentifier/url/https://elifesciences.org/articles/86527
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv eLife Sciences Publications Ltd
publisher.none.fl_str_mv eLife Sciences Publications Ltd
dc.source.none.fl_str_mv reponame:CONICET Digital (CONICET)
instname:Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str CONICET Digital (CONICET)
collection CONICET Digital (CONICET)
instname_str Consejo Nacional de Investigaciones Científicas y Técnicas
repository.name.fl_str_mv CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_ 1842268926382178304
score 13.13397